Could GLP-1 weight-loss medications like Ozempic become the ‘everything drug’?
GLP-1 agonists — including semaglutides like Ozempic and Wegovy and tirzepatides like Mounjaro and Zepbound — were originally intended to treat type 2 diabetes and obesity.
But in recent months, studies have shown that these popular medications can have numerous other health benefits.
Some have even claimed that GLP-1s could eventually become the new «everything drug.»
MEDITERRANEAN DIET PAIRED WITH OTHER LIFESTYLE CHANGES SLASHES DIABETES RISK
Dr. Angela Fitch, co-founder and chief medical officer of knownwell, a «weight-inclusive» healthcare company based in Boston, said she would caution against labeling any medication as an «everything drug,» but agrees that GLP-1s show promise.
«GLP-1s are currently approved for treating obesity, type 2 diabetes, secondary prevention of cardiovascular disease, metabolic associated fatty liver disease, chronic kidney disease in patients with diabetes and sleep apnea,» she told Fox News Digital.
«Further research is necessary to determine their eff..